The company: Anacor Pharmaceuticals, Inc. Sector: Healthcare Industry: Biotechnology Anacor focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Related Link: 4 Biotech Stocks With Big Money Coming In The company's lead product candidates include AN2728, an anti-inflammatory product candidate, which completed Phase II clinical trials for the treatment of atopic dermatitis and psoriasis, and chronic inflammatory skin diseases. Take a look at the 1-year chart of Anacor with added notations: As most market participants know, biotech stocks got hit pretty hard with the Nasdaq and Russell back in April and May.